WASHINGTON (Reuters) – A long-negotiated patent overhaul bill sought by technology companies and opposed by big pharmaceutical makers is in deep trouble in the U.S. Senate, Democratic and Republican aides said on Monday.
Tech-backed patent bill in trouble in U.S. Senate
WASHINGTON (Reuters) - A long-negotiated patent overhaul bill sought by technology companies and opposed by big pharmaceutical makers is in deep trouble in the U.S. Senate, Democratic and Republican aides said on Monday.
